Showing 11,221 - 11,240 results of 12,700 for search '"cancer"', query time: 0.08s Refine Results
  1. 11221

    Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors by Zhengyan Kan, Ji Wen, Vinicius Bonato, Jennifer Webster, Wenjing Yang, Vladimir Ivanov, Kimberly Hyunjung Kim, Whijae Roh, Chaoting Liu, Xinmeng Jasmine Mu, Jennifer Lapira-Miller, Jon Oyer, Todd VanArsdale, Paul A. Rejto, Jadwiga Bienkowska

    Published 2025-01-01
    “…Abstract To better understand drug resistance mechanisms to CDK4/6 inhibitors and inform precision medicine, we analyze real-world multi-omics data from 400 HR+/HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors plus endocrine therapies, including 200 pre-treatment and 227 post-progression samples. …”
    Get full text
    Article
  2. 11222

    Assessment of Radionuclide Concentration in Surface Soil and Human Health Risk Associated with Exposure in Two Higher Institutions of Esan land, Edo State, Nigeria by F.A. Popoola, O.D. Fakeye, Q.B. Basiru, D.A. Adesina, M.A. Sulola

    Published 2020-01-01
    “…The total mean values for radiation dose estimation for Radium Equivalent Activity, Absorbed Dose, Excess Lifetime Cancer Risk, Outdoor and Indoor Annual Effective Dose Equivalent are 13.20 BqKg-1, 6.03 nGy/ℎ, 0.026, 7.40 µSτ/γ and 29.60 µSτ/γ respectively. …”
    Get full text
    Article
  3. 11223

    Evaluating the occurrence of trihalomethanes in drinking water and their implications for human health risk by Victor Constantin Cojocaru, Valentina Andreea Petre, Ana Ioana Paris, Nicolae Ionut Cristea, Florentina Laura Chiriac, Ioana-Antonia Cimpean

    Published 2024-12-01
    “…Carcinogenic risk assessments indicate a similar trend, with total risks for women varying between 1.37×10-6 and 1.88×10-4, and for men between 2.22×10-7 and 1.66×10-4. comparable values for cancer risk that exceed the minimum or negligible risk threshold established by the USEPA (1.00×10-6).…”
    Get full text
    Article
  4. 11224
  5. 11225
  6. 11226

    Anti-Inflammatory Effects of Protein Kinase Inhibitor Pyrrol Derivate by Halyna M. Kuznietsova, Maryna S. Yena, Iryna P. Kotlyar, Olexandr V. Ogloblya, Volodymyr K. Rybalchenko

    Published 2016-01-01
    “…In our previous studies we showed antitumor and anti-inflammatory activities of protein kinases inhibitor pyrrol derivate 1-(4-Cl-benzyl)-3-Cl-4-(CF3-fenylamino)-1H-pyrrol-2,5-dione (MI-1) on rat colon cancer model. Therefore anti-inflammatory effect of MI-1 on rat acetic acid induced ulcerative colitis (UC) model was aimed to be discovered. …”
    Get full text
    Article
  7. 11227

    Characterization of ZnO nanoparticles synthesized using probiotic Lactiplantibacillus plantarum GP258 by Prashantkumar Siddappa Chakra, Aishwarya Banakar, Shriram Narayan Puranik, Vishwas Kaveeshwar, C. R. Ravikumar, Devaraja Gayathri

    Published 2025-01-01
    “…Additionally, the NPs were photocatalytically and electrochemically analyzed, indicating their potential use in cancer research as well as in coating and drug delivery applications.…”
    Get full text
    Article
  8. 11228

    Leukemia Stem Cell-Released Microvesicles Promote the Survival and Migration of Myeloid Leukemia Cells and These Effects Can Be Inhibited by MicroRNA34a Overexpression by Yue Wang, Qian Cheng, Jing Liu, Min Dong

    Published 2016-01-01
    “…Recent evidence indicates that microvesicles (MVs) released from cancer stem cells can promote tumor growth and invasion. …”
    Get full text
    Article
  9. 11229
  10. 11230

    Clinical Effect of Preservation or Nonpreservation of Left Colic Artery in Total Mesorectal Excision under Laparoscopy: A Meta-analysis by Jiefeng Liu, Yujing Gong, Miao He, Xinyu Zeng, Yiping Liu

    Published 2020-01-01
    “…The words, like “rectal cancer,” “left colonic artery,” and “laparoscopy,” were used as the retrieval terms, and the keyword retrieval method was adopted. …”
    Get full text
    Article
  11. 11231
  12. 11232

    In situ-formed cryomicroneedles for intradermal cell delivery by Mengjia Zheng, Tianli Hu, Yating Yang, Xuan Qie, Huaxin Yang, Yuyue Zhang, Qizheng Zhang, Ken-Tye Yong, Wei Liu, Chenjie Xu

    Published 2024-02-01
    “…As a proof-of-concept, we examined the loading and intradermal delivery of three cell types in clinically relevant in vitro and in vivo models, including mesenchymal stem cells for wound healing, melanocytes for vitiligo treatment, and antigen-pulsed dendritic cells for cancer vaccination.…”
    Get full text
    Article
  13. 11233
  14. 11234

    Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies by Bing Liu, Shishi Feng, Xuan Guo, Jing Zhang

    Published 2019-09-01
    “…We envisage the applications of more modified Bayesian methods to other infectious diseases and cancer cells that will be following with critical medical results before long.…”
    Get full text
    Article
  15. 11235
  16. 11236

    Assessing the influence of matcha green tea extract on NF-κB/MAPK signaling pathway activation in rats: A study on irradiation-induced acute hepatic inflammatory response by Noha Sayed Hamed, Eithar K. El Adham, Amal I. Hassan

    Published 2025-02-01
    “…Background: Numerous forms of cancer are frequently treated with radiation therapy, which provides substantial benefits in tumor control. …”
    Get full text
    Article
  17. 11237

    Efficient Implementation of Mahalanobis Distance on Ferroelectric FinFET Crossbar for Outlier Detection by Musaib Rafiq, Yogesh Singh Chauhan, Shubham Sahay

    Published 2024-01-01
    “…The proposed implementation utilizes two crossbar arrays of ferroelectric FinFETs to calculate the Mahalanobis distance and detect outliers in the popular Wisconsin breast cancer dataset using a novel inverter-based threshold circuit. …”
    Get full text
    Article
  18. 11238
  19. 11239

    An UPLC-MS/MS Method for Determination of Osimertinib in Rat Plasma: Application to Investigating the Effect of Ginsenoside Rg3 on the Pharmacokinetics of Osimertinib by Zhenzhen Ying, Jingyao Wei, Ruijuan Liu, Fang Zhao, Yifang Yu, Xin Tian

    Published 2020-01-01
    “…Osimertinib is a novel oral, potent, and irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) for treatment of advanced T790M mutation-positive advanced non-small cell lung cancer, which is commonly combined with ginsenoside Rg3 in clinic to enhance the efficacy and minimize adverse reactions. …”
    Get full text
    Article
  20. 11240